BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Chronic myeloid leukemia (CML) is a stem cell-derived hematological malignancy with genomic aberrations appearing in hematopoietic stem and progenitor cells characterized by a fusion oncogene BCR/ABL.